NAFDAC Sets The Record Straight: No Confirmation Of Substandard Paracetamol In Local Markets

NAFDAC Sets The Record Straight: No Confirmation Of Substandard Paracetamol In Local Markets....KINDLY READ THE FULL STORY HERE▶

The National Agency for Food and Drug Administration, NAFDAC, has responded to claims of the presence of substandard paracetamol in Nigeria’s pharmaceutical market. In a statement released on Monday, NAFDAC’s media consultant, Sayo Akintola, refuted the allegations, emphasizing that there is no substantiated evidence supporting the circulation of inferior quality paracetamol within the country……..CONTINUE READING

READ ALSO:https://bushradiogist.com/fcta-issues-stern-warning-violate-traffic-lights-and-prepare-for-consequences/

Addressing the concerns raised, Akintola assured the public that NAFDAC remains committed to ensuring the health and safety of the nation. He noted that the agency conducts an annual post-marketing survey of medicines, diligently monitoring the quality and safety of pharmaceutical products. Any deviations from established standards prompt NAFDAC to take necessary actions, such as issuing public alerts or recalls for regulated products found to be substandard or falsified.

In response to a purported research publication on the matter, Akintola categorically stated that the report is misleading, and he questioned the scientific credibility behind the findings. He reiterated NAFDAC’s dedication to vigilance in upholding the integrity of the nation’s health, emphasizing that the agency is proactive in addressing any issues related to the quality and authenticity of medicinal products.

In conclusion, NAFDAC reassured the public of its ongoing efforts to safeguard the nation’s health, emphasizing its commitment to maintaining the highest standards in the pharmaceutical market and swiftly responding to any identified risks or deviations from established quality parameters.

For more information join our WhatsApp group by clicking the link here: WhatsApp Group Invite